Phase 2 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 19 and 74 years old, and your body weight falls within a healthy to moderately overweight range (BMI under 40)
- You are generally in good health, as assessed by the lead doctor based on your medical history
- If you are a healthy volunteer, your blood pressure and resting heart rate are in a normal range without needing medication; if you have knee arthritis and high blood pressure, it must be well-controlled with medication, and your resting heart rate must be in a normal range
- If you are a woman who could become pregnant or who has gone through menopause less than a year ago, you must be using a reliable form of birth control (such as hormonal contraceptives, double barrier methods, or complete abstinence) for at least one full monthly cycle before taking the study drug
Who may not be able to join:
- You have had an allergic reaction or sensitivity to any ingredient in Pitocin® (a form of oxytocin)
- You have a medical or surgical condition that the lead doctor believes could put you at risk, affect your ability to follow the study procedures, or affect the quality of results (for example, certain uterine conditions with active bleeding)
- You are currently pregnant, breastfeeding, or have been pregnant within the last 2 years
- You have nerve damage (neuropathy), chronic pain, diabetes, or you take benzodiazepines or pain medications every day
- You have eye problems, have had eye surgery, use eye drops regularly, or have any condition that causes shaking or unusual eye movements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: James C Eisenach, MD, Wake Forest University Health Sciences
Phone: 336-716-4294
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Fluctuation in Pupil Diameter (Hippus) -Pre drug administration; Fluctuation in Pupil Diameter (Hippus) -Post drug administration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.